[144] IMAX CORP SEC Filing
IMAX Corp filed a Form 144 to notify a proposed sale of 20,000 Class A Common Shares through Merrill Lynch on the NYSE with an approximate sale date of 09/15/2025. The filing reports an aggregate market value of $656,029 against 53,782,520 shares outstanding, indicating the sale represents a small fraction of the company's outstanding stock.
The 20,000 shares were acquired through vesting of restricted stock units (RSUs) issued as compensation on dates between 02/21/2018 and 03/07/2021 (2,456; 1,869; 15,203; 472 respectively). No securities sales by the filer in the past three months are reported, and the filer certifies no undisclosed material adverse information.
- None.
- None.
Insights
TL;DR: Routine insider sale notice for 20,000 vested RSU shares, immaterial relative to outstanding shares.
The Form 144 documents a proposed sale of 20,000 Class A shares via Merrill Lynch, valued at $656,029, against 53.78 million shares outstanding (≈0.037% of outstanding). The securities were received from RSU vesting between 2018 and 2021, confirming compensation-originated holdings rather than a secondary issuance. No recent sales in the prior three months are reported by the filer. This is a standard compliance filing and likely neutral for IMAX's near-term market dynamics.
TL;DR: Compliance disclosure of an insider's planned sale; disclosure aligns with Rule 144 requirements.
The notice provides required information: broker, share count, market value, acquisition history and compensation origin (RSU vesting). The filer represents no undisclosed material adverse information and there is no indication of reliance on a 10b5-1 plan in the filing. From a governance perspective, the form meets disclosure obligations; the transaction size appears immaterial to shareholder control or dilution.